Browse By

Daily Archives: January 16, 2020

[Cannabis] Compass Pathways Obtains Patent For Psilocybin Depression Treatment

Mental health care company COMPASS Pathways said Monday it has received a U.S. patent for its method of treating drug-resistant depression using a psilocybin formulation. The patent includes the use of Compass' synthesized investigational psilocybin formulation COMP360 that targets patients with treatment-resistant depression. The company previously reported that